CHAPEL HILL, N.C.--(BUSINESS WIRE)--Jul. 27, 2015--
POZEN Inc. (NASDAQ: POZN) announced today that it plans to
release second quarter 2015 results on August 10, 2015, before the
market opens.
The announcement will be followed by a live webcast at 2:00 p.m. (EDT)
with a discussion by POZEN management of the earnings and business
results. The webcast can be accessed on POZEN’s website at www.pozen.com
and will be archived and available for replay. The second quarter 2015
earnings release will be accessible in the Media section of POZEN’s
website.
About POZEN
POZEN Inc. is a specialty pharmaceutical company that to date has
historically focused on developing novel therapeutics for unmet medical
needs and licensing those products to other pharmaceutical companies for
commercialization. By utilizing a unique in-source model and focusing on
integrated therapies, POZEN has successfully developed and obtained FDA
approval of two self-invented products. Funded by these
milestones/royalty streams, POZEN has created a portfolio of
cost-effective, evidence-based integrated aspirin therapies designed to
enable the full power of aspirin by reducing its GI damage.
POZEN’s common stock is traded under the symbol “POZN” on The NASDAQ
Global Market. For more detailed company information, including copies
of this and other press releases, please visit www.pozen.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150727005146/en/
Source: POZEN Inc.
POZEN Inc.
Bill Hodges, 919-913-1030
Chief
Financial Officer
or
Nichol Ochsner, 919-913-1030
Executive
Director, Investor Relations & Corporate Communications
